Search PubMed⌕ Search

Biomedical subjects

K Grauer

Publications and source records attributed to K Grauer.

60 records · Page 4Linked to original sources
PubMedDate not supplied

Potential benefits of a computer ECG interpretation system for primary care physicians in a community hospital.

One hundred fifteen ECGs from a hospital service were interpreted by 2 primary care physicians and 2 expert electrocardiographers. When their interpretations were compared with one another and with the Marquette MAC II ECG Interpretation Program, there was great variability. Computer ECG interpretations appeared to benefit primary care physicians most by providing a backup opinion. This second opinion was also of use to expert electrocardiographers. Additional long-term benefits that may be derived from computer systems include improvement of physician interpretation ability, reduction in interpretation time, and standardization of electrocardiographic nomenclature and criteria.

Diagnosis, Computer-Assisted↗
PubMedDate not supplied

Ventricular arrhythmias, Part II: Special concerns in evaluation.

In the initial installment of this series, the prevalence, significance, and indications for treatment of ventricular arrhythmias were discussed. In this section, we address special concerns in the evaluation of patients with ventricular arrhythmias including the importance of extracardiac and exacerbating factors, the likely role of silent myocardial ischemia, benefits and drawbacks of monitoring methods, proarrhythmic effect, and torsades de pointes. Treatment considerations and discussion of pitfalls in management will follow in the final two installments of this series.

Electrocardiography↗
PubMedDate not supplied

Ventricular arrhythmias, Part III: Benefits and risks of antiarrhythmic therapy.

In Parts I and II of this series, clinical significance, prevalence, and special concerns in the evaluation of patients with ventricular arrhythmias were reviewed. We now examine the categories of antiarrhythmic drugs and offer indications for their use. Reasons why a patient may not respond to antiarrhythmic therapy, end points of therapy, and the benefits and drawbacks of measuring serum drug levels are addressed. Use of newer drugs and additional treatment modalities are discussed in the final installment.

Anti-Arrhythmia Agents↗
PubMedDate not supplied

Ventricular arrhythmias, conclusion: new agents, additional treatment modalities, and overall approach to the problem.

In this final installment, we discuss use of the newer antiarrhythmic agents and indications for additional treatment modalities such as programmed electrophysiologic stimulation (PES), surgery, and implantation of the automatic cardioverter-defibrillator. We conclude with our approach for evaluating the efficacy of antiarrhythmic therapy.

Anti-Arrhythmia Agents↗
PubMedDate not supplied

On mouth-to-mouth.

Health care providers are becoming increasingly reluctant to perform mouth-to-mouth resuscitation. While it may be prudent to exercise caution in this endeavor, it is important to appreciate the potential consequences of delaying this lifesaving procedure.

Acquired Immunodeficiency Syndrome↗